Last reviewed · How we verify
Metastatic colorectal cancer — Treatment Landscape & Competitive Intelligence
2 marketed
0 Phase 3
0 Phase 2
Live · 30-min refresh
Marketed treatment landscape
| Drug | Generic | Sponsor | Class | Target | Line of therapy | First approval |
|---|---|---|---|---|---|---|
| Folfiri | folfiri | Pfizer | chemotherapy | DNA replication and repair | ||
| Folfox-7 | folfox-7 | Pfizer | chemotherapy | DNA replication machinery |
Phase 3 pipeline
Phase 2 pipeline
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Sponsor landscape
- Pfizer · 2 drugs in Metastatic colorectal cancer
- Pfizer Inc. · 2 drugs in Metastatic colorectal cancer
- · 1 drug in Metastatic colorectal cancer
Subscribe to ongoing alerts
Every new regulatory action, PDUFA date, or trial completion in Metastatic colorectal cancer:
- Metastatic colorectal cancer treatment updates — RSS
- Metastatic colorectal cancer treatment updates — Atom
- Metastatic colorectal cancer treatment updates — JSON
Cite this brief
Drug Landscape (2026). Metastatic colorectal cancer — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/metastatic-colorectal-cancer. Accessed 2026-06-10.
Related
- Metastatic colorectal cancer full disease profile — treatment pathway, diagnostics, guidelines
- Browse all CI briefs
- Build a custom feed
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing